Page 24 - Platelets News Today

Samaritan rescued the girl and she was flown here, broken and battered. left leg shattered. skull fractured. a small collection of blood on her brain, but, yes, very much alive. such an incredible story, anderson, i mean, just think about that building that you saw there. she was asleep in a cot next to that window. had she been in that cot, still in that cot she would have most likely died just by what had happened to that building. instead she was thrown out of the building and survived. as yo...

© Provided by Xinhua TIANJIN, Feb. 6 (Xinhua) -- After finishing a physical examination and giving a blood sample, Peter Mecoy deftly rolled up his sle

Despite evidence that starting two blood-thinning medications shortly after a minor stroke or a warning stroke (transient ischemic attack - TIA) may prevent a second – possibly more serious – clot-caused stroke within a few months, the treatment regimen is underused especially among women, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial.

The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Having unmasked a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis), researchers from the University of Birmingham have now turning their attention to sepsis. Click to read more...

Six minutes of high-intensity cycling increases production of a key protein that promotes neuroplasticity, learning, and memory ― which could help protect the aging brain, new research suggests.

Platelet-rich plasma (PRP) is a concentration of platelets in blood plasma used to stimulate hair growth and improve scalp health.

At ASH 2022, experts discuss how the virus breaches the immune system and how to recognize vaccine-related blood clots.

Researchers provided an overview of nanomedicine strategies to treat coronavirus disease 2019 (COVID-19)-induced thrombosis.